Medtronic unveils Endeavor Sprint drug eluting stent on a rapid exchange
Medtronic, Inc. has launched the Endeavor Sprint drug eluting stent (DES) on a rapid exchange (RX) delivery system in the U.S. The Endeavor Sprint system uses Sprinter ™ balloon catheter technology. The system puts the highly deliverable Endeavor DES on an enhanced delivery platform. This makes Medtronic’s flagship DES even easier for physicians to deliver to the site of coronary blockages. The Endeavor Sprint drug eluting stent system is the latest innovation to come out of our robust product pipeline in CardioVascular.
- Medtronic Launches Sprinter(R) Angioplasty Balloon Cathethers On Rapid Exchange
- XIENCE V Everolimus Eluting stent more effective than TAXUS Paclitaxel-Eluting stent
- FDA approves market launch of Boston Scientific’s DES
- Tryton launches Side Branch Stent System™ in Europe
